CLINICAL_TRIALS
trial_result
· 2026-07-07
Clinical Trial Update: Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee [Phase 3]
Summary
Phase 3 trial update for TG-C in knee osteoarthritis (Kellgren/Lawrence grade 2-3) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kolon TissueGene, Inc. | Conditions: Degenerative Osteoarthritis | Phase 3 | Status: COMPLETED